Avita Medical Inc. cash flow to debt ratio of -67.74% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Avita Medical Inc.'s free cash flow has increased -43.48% from $-58.27M last year to $-32.93M, signaling increasing performance

Avita Medical Inc.'s debt to equity ratio is -0.07, signaling that the company spent its equity and risk bankruptcy.

Avita Medical Inc.'s debt to equity ratio is -0.07, signaling that the company spent its equity and risk bankruptcy.

Avita Medical Inc. has negative EBITDA, making leverage ratio unreliable

Avita Medical Inc.'s interest coverage ratio is -6.52, which means that the company struggles to meet interest obligations, signaling financial risk.

Avita Medical Inc.'s profit margin has increased (-40.82%) in the last year from -96.26% to -56.96%, signaling increasing performance

Avita Medical Inc.'s short-term liabilities of $62.68M exceed its short-term assets of $35.49M, signaling financial risk

Avita Medical Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Avita Medical Inc.'s return on equity of 231.87%, is higher than 15.00%, indicating good performance

Avita Medical Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Avita Medical Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings

Avita Medical Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Avita Medical Inc. has negative free cash flow, indicating cash burn

Avita Medical Inc.'s yearly earnings has increased -21.44% since last year from $-61.84M to $-48.59M, signaling increasing performance

Avita Medical Inc.'s yearly revenue has increased 11.45% since last year from $64.25M to $71.61M, signaling increasing performance

ROIC 168.21% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.

Avita Medical Inc.'s 3-year revenue CAGR of 27.66% is positive, indicating growing revenue over the past 3 years

Avita Medical Inc. had revenue growth in 5 out of 5 years, indicating consistent revenue performance

Avita Medical Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

Avita Medical Inc. has insufficient data to evaluate this check.

Avita Medical Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Avita Medical Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Avita Medical Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Avita Medical Inc. is overvalued relative to its fair value price of -39.75 based on Earnings Fair Value model

Avita Medical Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Avita Medical Inc. has negative shareholder equity; price-to-book is not meaningful and the check fails

Avita Medical Inc. has a price-to-sales ratio of 3.09x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue